New hope for lung cancer: drug duo targets tough-to-treat SCLC
Disease control
Recruiting now
This study tests two immunotherapy drugs (monalizumab and durvalumab) with or without chemotherapy for small cell lung cancer (SCLC). It includes 84 adults with either extensive-stage or limited-stage SCLC. The goal is to see if the combination helps control the cancer longer and…
Phase: PHASE2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated May 17, 2026 04:17 UTC